Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuromuscular blocking agents.

C J Lingle1, J H Steinbach

  • 1Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO.

International Anesthesiology Clinics
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors.

British journal of pharmacology·2014
Same author

Developmental changes in acetylcholine receptor aggregates at rat skeletal neuromuscular junctions.

Developmental biology·2010
Same author

Structurally diverse amphiphiles exhibit biphasic modulation of GABAA receptors: similarities and differences with neurosteroid actions.

British journal of pharmacology·2010
Same author

Actions of anesthetics on excitatory transmitter-gated channels.

Handbook of experimental pharmacology·2008
Same author

Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate.

British journal of pharmacology·2007
Same author

A slip 'twixt the cup and the lip: a new way to impair function of transmitter-gated channels.

The Journal of physiology·2007

Neuromuscular blockers’ molecular actions are not fully understood. Future research should investigate presynaptic effects, variability factors, desensitization, and channel interactions for a comprehensive understanding of neuromuscular blockade.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • The precise molecular mechanisms underlying neuromuscular blockers' actions are not fully elucidated.
  • Competitive blockers primarily act by binding to acetylcholine receptors, while depolarizing blockers present more complex mechanisms involving depolarization and inactivation.

Purpose of the Study:

  • To review the current understanding of neuromuscular blocker actions at the molecular level.
  • To identify key areas requiring further investigation, including presynaptic effects, variability factors, and specific blocking mechanisms.

Main Methods:

  • Literature review and theoretical discussion of existing data on neuromuscular blockers.
  • Identification of unresolved questions and proposed avenues for future research.

Related Experiment Videos

Main Results:

  • Competitive blockade is primarily postsynaptic via acetylcholine receptor binding.
  • Depolarizing blockade involves postsynaptic depolarization and inactivation, with potential presynaptic contributions and desensitization effects.
  • Significant gaps exist in understanding presynaptic actions, inter-species/intra-species variability, desensitization roles, and channel-related blocking mechanisms.

Conclusions:

  • Further research is crucial to understand the presynaptic effects of cholinergic drugs and their interaction with ion channels.
  • Investigating factors influencing variability in neuromuscular blocker sensitivity is essential.
  • Exploring the roles of desensitization and channel trapping/blockade will advance the understanding of neuromuscular blockade mechanisms.